Neutrophil elastase: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
== | {{Infobox enzyme | ||
| name = Neutrophil elastase | |||
| image = <!-- Image removed --> | |||
| width = | |||
| caption = | |||
| EC_number = 3.4.21.37 | |||
| CAS_number = 9004-06-2 | |||
| GO_code = 0004252 | |||
}} | |||
[[ | '''Neutrophil elastase''' is a [[serine protease]] enzyme that is primarily found in [[neutrophils]], a type of [[white blood cell]]. It plays a crucial role in the [[immune system]] by breaking down [[proteins]] and [[peptides]] during the process of [[phagocytosis]]. | ||
== | == Function == | ||
Neutrophil elastase is involved in the degradation of various [[extracellular matrix]] proteins, including [[elastin]], [[collagen]], and [[fibronectin]]. This activity is essential for the [[immune response]], allowing neutrophils to migrate through tissues to reach sites of [[infection]] or [[inflammation]]. | |||
== Clinical Significance == | |||
Excessive activity of neutrophil elastase can lead to tissue damage and is associated with several [[diseases]]. For example, in [[chronic obstructive pulmonary disease]] (COPD), the enzyme contributes to the destruction of [[lung tissue]]. In [[cystic fibrosis]], neutrophil elastase is involved in the degradation of [[lung]] [[epithelial cells]], exacerbating the disease. | |||
== | == Regulation == | ||
The activity of neutrophil elastase is tightly regulated by [[endogenous]] inhibitors such as [[alpha-1 antitrypsin]]. A deficiency in alpha-1 antitrypsin can lead to unregulated activity of neutrophil elastase, resulting in conditions like [[emphysema]]. | |||
== Therapeutic Target == | |||
Neutrophil elastase is a target for therapeutic intervention in diseases where its activity is detrimental. [[Inhibitors]] of neutrophil elastase are being developed to treat conditions such as [[COPD]] and [[cystic fibrosis]]. | |||
== | == See Also == | ||
* [[Serine protease]] | |||
* [[Alpha-1 antitrypsin]] | |||
* [[Chronic obstructive pulmonary disease]] | |||
* [[Cystic fibrosis]] | |||
== References == | |||
{{Reflist}} | |||
== | == External Links == | ||
* [ | * [https://www.wikimd.com/wiki/Neutrophil_elastase Neutrophil elastase on WikiMD] | ||
[[Category:Enzymes]] | [[Category:Enzymes]] | ||
[[Category:Proteases]] | |||
[[Category:Immune system]] | [[Category:Immune system]] | ||
[[Category: | [[Category:Pulmonology]] | ||
Latest revision as of 16:57, 29 December 2024
Neutrophil elastase
Neutrophil elastase is a serine protease enzyme that is primarily found in neutrophils, a type of white blood cell. It plays a crucial role in the immune system by breaking down proteins and peptides during the process of phagocytosis.
Function[edit]
Neutrophil elastase is involved in the degradation of various extracellular matrix proteins, including elastin, collagen, and fibronectin. This activity is essential for the immune response, allowing neutrophils to migrate through tissues to reach sites of infection or inflammation.
Clinical Significance[edit]
Excessive activity of neutrophil elastase can lead to tissue damage and is associated with several diseases. For example, in chronic obstructive pulmonary disease (COPD), the enzyme contributes to the destruction of lung tissue. In cystic fibrosis, neutrophil elastase is involved in the degradation of lung epithelial cells, exacerbating the disease.
Regulation[edit]
The activity of neutrophil elastase is tightly regulated by endogenous inhibitors such as alpha-1 antitrypsin. A deficiency in alpha-1 antitrypsin can lead to unregulated activity of neutrophil elastase, resulting in conditions like emphysema.
Therapeutic Target[edit]
Neutrophil elastase is a target for therapeutic intervention in diseases where its activity is detrimental. Inhibitors of neutrophil elastase are being developed to treat conditions such as COPD and cystic fibrosis.
See Also[edit]
References[edit]
<references group="" responsive="1"></references>